Insider Transactions in Q4 2023 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+8.1%
|
-
|
|
Dec 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+7.49%
|
-
|
|
Dec 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.5%
|
-
|
|
Dec 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+14.54%
|
-
|
|
Dec 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+15.68%
|
-
|